Clinical utility of assessing PTEN and ERG protein expression in prostate cancer patients: a proposed method for risk stratification.

Tarek A BismarSamar HegazyZhaoyong FengDarryl YuBryan DonnellyNallasivam PalanisamyBruce J Trock

Published in: Journal of cancer research and clinical oncology (2018)

This study confirms a significant prognostic role for assessing ERG and PTEN in men with prostate cancer. It supports a role for utilizing combined ERG/PTEN status clinically and prospectively for stratifying PCa patients into different prognostic groups.

Keyphrases

prostate cancer
cell proliferation
pi k akt
end stage renal disease
ejection fraction
newly diagnosed
radical prostatectomy
chronic kidney disease
prognostic factors
signaling pathway